Neo Modulus (Suzhou) Medical Sci-Tech Co., Ltd. – Trademark Portfolio
Entity Type: 99
Neo Modulus (Suzhou) Medical Sci-Tech Co., Ltd. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 5 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include NEO MODULUS.
Room 301, 302, Building 11,
No. 8, Jinfeng Road, High-tech Zone, Suzhou 215011 Jiangsu
Showing of trademarks Trademarks
Trademark Classifications
Neo Modulus (Suzhou) Medical Sci-Tech Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Neo Modulus (Suzhou) Medical Sci-Tech Co., Ltd. have?
Neo Modulus (Suzhou) Medical Sci-Tech Co., Ltd. has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Neo Modulus (Suzhou) Medical Sci-Tech Co., Ltd. file in?
Neo Modulus (Suzhou) Medical Sci-Tech Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Neo Modulus (Suzhou) Medical Sci-Tech Co., Ltd.'s most well-known trademarks?
Neo Modulus (Suzhou) Medical Sci-Tech Co., Ltd.'s registered trademark portfolio includes well-known marks such as NEO MODULUS. These are among 2 currently registered trademarks in the portfolio.
What is Neo Modulus (Suzhou) Medical Sci-Tech Co., Ltd.'s trademark registration success rate?
Neo Modulus (Suzhou) Medical Sci-Tech Co., Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.